Sentieon makes accelerated bioinformatics software for genomic data analysis, used in healthcare and life sciences.
Sentieon Inc develops bioinformatics secondary analysis tools for genomic data, including CPU and ARM-accelerated replacements for tools such as BWA-MEM, STAR, Minimap2, GATK, and Mutect2, and the DNAscope pipeline for short and long reads. Clients in healthcare and life sciences license the software through subscriptions or licensing agreements. Founded in 2014 and based in San Jose, US, the company raised an undisclosed SEED round from 3E Bioventures Capital on August 1, 2015. CEO Jun Ye leads it.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in